New platforms for coronary lesions treatment

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: A. V. Marinho, O. Toleva

Speakers: U. Kaul, E. Acar, C. T. Shih, M. Lutz, A. Monastyrski, Y. Xiaolin

Summary

Delve into the latest developments in coronary lesion treatment platforms through this session, highlighting real-world performance data of novel drug-eluting stents like Eternia and Evermine 50. It also presents preclinical insights on biomimetic CD31-coated stents, long-term outcomes of the Fantom BRS platform, and innovative randomized trials assessing endothelialisation. Furthermore, the session evaluates the safety and efficacy of a 5G Tele-Robotic PCI platform, showcasing advanced interventional technologies.

Presentations available when logged in:

Peri-procedural performance of Eternia Everolimus eluting coronary stent: real-world experience
STELLAR registry: real-world outcomes of the Evermine 50 ultrathin everolimus-eluting stent
Comparison of the first and next generation device of the Fantom BRS platform clinical longterm data
Multicenter randomised trial of early endothelialisation with OCT in free and durable polymer stents

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

New platforms for coronary lesions treatment

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free